Eton Pharma Chief Business Officer David Krempa disposes of 99,999 common shares worth USD 3.24 million

Eton Pharmaceuticals, Inc.

ETON

0.00

Eton Pharmaceuticals Chief Business Officer David Krempa reported option exercises and share sales in late May.
Krempa exercised employee stock options for 87,794 shares at USD 1.37–USD 3.58 on May 22–27.
He sold 100,000 shares at weighted-average prices of about USD 31.47–USD 35 over May 22–27.
His direct common stock holdings fell to 25,249 shares following the transactions.
His remaining employee stock options totaled 118,406 shares after the reported exercises.

Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Eton Pharmaceuticals Inc. published the original content used to generate this news brief via EDGAR, the Electronic Data Gathering, Analysis, and Retrieval system operated by the U.S. Securities and Exchange Commission (Ref. ID: 0001437749-26-018628), on May 27, 2026, and is solely responsible for the information contained therein.

More This page is machine-translated. Sahm tries to improve but does not guarantee the accuracy and reliability of the translation, and will not be liable for any loss or damage caused by any inaccuracy or omission of the translation. *Disclaimer: The above content only represents the author's personal position and opinion and does not represent any position of Sahm Capital Financial Company and Sahm cannot confirm the authenticity, accuracy, and originality of the above content. Investors should consider the risks of investment products in light of their circumstances before making any investment decisions. When necessary, please consult a professional investment advisor. Sahm does not provide any investment advice, nor does it make any commitments and guarantees.